Dynamics-Based Peptide-MHC Binding Optimization by a Convolutional Variational Autoencoder: A Use-Case Model for CASTELO.
暂无分享,去创建一个
Guojing Cong | Leili Zhang | Giacomo Domeniconi | Chih-Chieh Yang | Ruhong Zhou | David Bell | David R. Bell | R. Zhou | Leili Zhang | Giacomo Domeniconi | Chih-Chieh Yang | Guojing Cong
[1] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[2] Andrew K. Sewell,et al. Why must T cells be cross-reactive? , 2012, Nature Reviews Immunology.
[3] Aristides Gionis,et al. Clustering aggregation , 2005, 21st International Conference on Data Engineering (ICDE'05).
[4] J. Strominger,et al. Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] Guojing Cong,et al. CASTELO: clustered atom subtypes aided lead optimization—a combined machine learning and molecular modeling method , 2020, BMC Bioinformatics.
[6] Serena H. Chen,et al. Graphene-extracted membrane lipids facilitate the activation of integrin αvβ8. , 2020, Nanoscale.
[7] CASTELO: clustered atom subtypes aided lead optimization—a combined machine learning and molecular modeling method , 2021, BMC Bioinform..
[8] James McCluskey,et al. T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.
[9] T. Lybrand,et al. Polymorphic Amino Acid Variations in HLA-DQ Are Associated With Systematic Physical Property Changes and Occurrence of IDDM , 1995, Diabetes.
[10] Irini Doytchinova,et al. Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach , 2011, BMC Structural Biology.
[11] B. Walker,et al. T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable , 2018, Proceedings of the National Academy of Sciences.
[12] E. Unanue,et al. Register shifting of an insulin peptide–MHC complex allows diabetogenic T cells to escape thymic deletion , 2011, The Journal of experimental medicine.
[13] Yi Wang,et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. , 2020, The Journal of chemical physics.
[14] B. Baker,et al. Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design1 , 2005, The Journal of Immunology.
[15] A. Sewell,et al. Structural basis for ineffective T-cell responses to MHC anchor residue-improved “heteroclitic” peptides , 2014, European journal of immunology.
[16] Jayvee R. Abella,et al. Structure-based Methods for Binding Mode and Binding Affinity Prediction for Peptide-MHC Complexes. , 2019, Current topics in medicinal chemistry.
[17] Carl Doersch,et al. Tutorial on Variational Autoencoders , 2016, ArXiv.
[18] Yuko Tsuchiya,et al. Autoencoder-Based Detection of Dynamic Allostery Triggered by Ligand Binding Based on Molecular Dynamics , 2019, J. Chem. Inf. Model..
[19] John Gounley,et al. How Distinct Structural Flexibility within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets , 2021, 2021 IEEE International Conference on Big Data (Big Data).
[20] Ron Elber,et al. Comprehensive analysis of sequences of a protein switch , 2016, Protein science : a publication of the Protein Society.
[21] R. Zhou,et al. Lanosterol Disrupts Aggregation of Human γD-Crystallin by Binding to the Hydrophobic Dimerization Interface. , 2018, Journal of the American Chemical Society.
[22] William S. Lane,et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.
[23] Z. Weng,et al. A flexible docking approach for prediction of T cell receptor–peptide–MHC complexes , 2013, Protein science : a publication of the Protein Society.
[24] E. Unanue,et al. Variations in MHC Class II Antigen Processing and Presentation in Health and Disease. , 2016, Annual review of immunology.
[25] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[26] Ruhong Zhou,et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen , 2019, Cell.
[27] Morten Nielsen,et al. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data , 2020, Nucleic Acids Res..
[28] Frank Noé,et al. MHC class II complexes sample intermediate states along the peptide exchange pathway , 2016, Nature Communications.
[29] Oliver Kohlbacher,et al. Immunoinformatics and epitope prediction in the age of genomic medicine , 2015, Genome Medicine.
[30] Morten Nielsen,et al. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. , 2020, Journal of proteome research.
[31] P. Marrack,et al. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register , 2010, Proceedings of the National Academy of Sciences.
[32] Ricardo J. G. B. Campello,et al. Density-Based Clustering Based on Hierarchical Density Estimates , 2013, PAKDD.
[33] Hau-San Wong,et al. TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules , 2012, PloS one.
[34] E. Unanue,et al. The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form1 , 2007, The Journal of Immunology.
[35] Jayvee R. Abella,et al. APE-Gen: A Fast Method for Generating Ensembles of Bound Peptide-MHC Conformations , 2019, Molecules.
[36] T. Lybrand,et al. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. , 1995 .
[37] E. Bergseng,et al. Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin. , 2006, Journal of the American Chemical Society.
[38] David R. Bell,et al. Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. , 2020, JCI insight.
[39] Morten Nielsen,et al. NetMHCpan 4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data , 2017, bioRxiv.
[40] Kristin Ladell,et al. Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition , 2010, The Journal of Immunology.
[41] Alex Rubinsteyn,et al. MHCflurry: Open-Source Class I MHC Binding Affinity Prediction. , 2018, Cell systems.
[42] Jing Huang,et al. CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data , 2013, J. Comput. Chem..
[43] Alessandro Laio,et al. Predicting the affinity of peptides to MHC class II by scoring molecular dynamics simulations. , 2019, Journal of chemical information and modeling.
[44] Zheng Pu,et al. Amino-Terminal Flanking Residues Determine the Conformation of a Peptide–Class II MHC Complex1 , 2006, The Journal of Immunology.
[45] P. Marrack,et al. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes , 2019, Science Immunology.
[46] P. Jensen,et al. Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes , 2013, Front. Immunol..
[47] M. Berger,et al. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy , 2018, Science.
[48] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD on the IBM Blue Gene/L system , 2008, IBM J. Res. Dev..
[49] P. Lackner,et al. MHCII3D—Robust Structure Based Prediction of MHC II Binding Peptides , 2020, International journal of molecular sciences.
[50] T. Huynh,et al. Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding. , 2012, Biophysical journal.
[51] P. Marrack,et al. C-terminal modification of the insulin B:11–23 peptide creates superagonists in mouse and human type 1 diabetes , 2017, Proceedings of the National Academy of Sciences.
[52] Ron Elber,et al. The energy landscape of a protein switch. , 2014, Physical chemistry chemical physics : PCCP.
[53] B. Walker,et al. The complex and specific pMHC interactions with diverse HIV-1 TCR clonotypes reveal a structural basis for alterations in CTL function , 2014, Scientific Reports.
[54] Eaman Alhassan,et al. Novel Nondietary Therapies for Celiac Disease , 2019, Cellular and molecular gastroenterology and hepatology.
[55] Irini Doytchinova,et al. T-cell epitope vaccine design by immunoinformatics , 2013, Open Biology.
[56] Claude Beazley,et al. A Novel Predictive Technique for the MHC Class II Peptide-Binding Interaction , 2003, Molecular medicine.
[57] Gabriella Sármay,et al. Antigen-specific immunotherapies in rheumatic diseases , 2017, Nature Reviews Rheumatology.
[58] Jayvee R. Abella,et al. HLA-Arena: A Customizable Environment for the Structural Modeling and Analysis of Peptide-HLA Complexes for Cancer Immunotherapy , 2020, JCO clinical cancer informatics.
[59] Shang Gao,et al. Deep clustering of protein folding simulations , 2018, BMC Bioinformatics.
[60] Charlotte M. Deane,et al. Current status and future challenges in T-cell receptor/peptide/MHC molecular dynamics simulations , 2015, Briefings Bioinform..
[61] Marcus D. Hanwell,et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.
[62] W. Langridge,et al. Autoantigen based vaccines for type 1 diabetes. , 2011, Discovery medicine.
[63] Serena H. Chen,et al. Charging nanoparticles: increased binding of Gd@C82(OH)22 derivatives to human MMP-9. , 2018, Nanoscale.
[64] David R. Bell,et al. In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers , 2020, Proceedings of the National Academy of Sciences.
[65] Morten Nielsen,et al. MHC Class II epitope predictive algorithms , 2010, Immunology.
[66] B. Luan,et al. Parameterization of Molybdenum Disulfide Interacting with Water Using Free Energy Perturbation Method. , 2019, The journal of physical chemistry. B.
[67] Zhiping Weng,et al. High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides , 2020, Bioinform..
[68] Frank Noé,et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation , 2017, Front. Immunol..
[69] Didier Devaurs,et al. General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept , 2018, Scientific Reports.
[70] P. Petrone,et al. MHC-peptide binding is assisted by bound water molecules. , 2004, Journal of molecular biology.
[71] Weilong Zhao,et al. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes , 2018, PLoS Comput. Biol..
[72] R. Zhou,et al. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase , 2020, The journal of physical chemistry. B.